课题基金 / 基金详情

Preventing medication errors due to unsafe electronic prescription transactions with just-in-time feedback

Preventing medication errors due to unsafe electronic prescription transactions with just-in-time feedback
通过及时反馈防止因不安全的电子处方交易而导致的用药错误
批准号:
10555718
负责人:
Corey A Lester
金额:
$49.3万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2025-09-29

项目摘要

项目成果

Corey A Lester的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Although electronic prescriptions (e-prescriptions) have improved patient safety in some ways, they have introduced new types of errors that can lead to significant harm to patients up to 4.39 million times each year. During e-prescription processing, medication errors occur when the medication prescribed by a physician is a different ingredient, strength, or dosage form compared to the medication dispensed by the pharmacist. Major reasons these unsafe e-prescription transactions exist include mismatching free-text drug descriptions with National Drug Codes (NDCs) and erroneous product selection in computer software used by prescribers and pharmacists. These unsafe e-prescription transactions are resulting in dangerous medication errors that may lead to significant patient harm. To systematically identify unsafe e-prescription transactions, we have developed a system, called SAVE-Rx, that uses e-prescription transaction data to automatically identify cases where the NDC prescribed does not match either the free-text drug description (i.e., an e-prescribing error) or the NDC of the medication dispensed by the pharmacy. Our system matches NDCs and free-text drug descriptions on the basis of medication ingredient, strength, and dosage form using standardized drug terminology from National Library of Medicine’s RxNorm. Unsafe e-prescription transactions are then reviewed by a safety team and communicated just-in-time to healthcare organizations, through existing e-prescription workflows, before they can cause harm to patients. Our long-term goal is to improve medication safety through the strategic use of automation in medication prescribing and dispensing workflows. The overall objective of this study is to determine the effect of implementing just-in-time feedback on the prevention of medication errors during e-prescription transactions between healthcare organizations. Aim 1 refines the design of a just- in-time feedback intervention, SAVE-Rx, and its implementation guide to identify unsafe e-prescription transactions. Aim 2 evaluates the implementation of the just-in-time feedback intervention for preventing unsafe e-prescription transactions. Our hypothesis is that we can improve the use of the intervention and alert performance by actively discontinuing alerts for safe mismatching pairs. Aim 3 determines the effects of the just-in-time feedback intervention on medication safety outcomes. Our hypothesis is that just-in-time feedback to healthcare organizations about unsafe e-prescription transactions will prevent clinically significant medication safety events. Accomplishing these aims will have a positive impact by testing a tool that is capable of actively monitoring and communicating useful feedback to healthcare organizations about unsafe e- prescription transactions on the more than 2 billion new e-prescription transmitted each year in the United States. At the end of this study, we expect to prevent at least 6,000 medication safety events as a result of implementing SAVE-Rx monitoring on 44 million e-prescription transactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preventing medication errors due to unsafe electronic prescription transactions with just-in-time feedback
海外基金